Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Ispire Technology Inc. manufactures e-cigarettes and cannabis vaping products. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc. operates as a subsidiary of Pride Worldwide Investment Limited

Ispire Technology Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

COMPANY TO SHOWCASE FULLY REENGINEERED PORTFOLIO; EXECUTIVE TEAM, INCLUDING HEAD OF SALES JOHN MONDS, AVAILABLE FOR ON-SITE MEETINGS LOS ANGELES , NOV. 26, 2025 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. (NASDA Q: ISPR) ("ISPIRE," OR THE "COMPANY"), ANNOUNCED THAT IT WILL UNVEIL ITS FULLY REENGINEERED CANNABIS PRODUCT ECOSYSTEM AT MJBIZCON 2025 , THE WORLD'S LARGEST CANNABIS INDUSTRY CONFERENCE AND TRADE SHOW. HELD DECEMBER 25 AT THE LAS VEGAS CONVENTION CENTER, THE EVENT WILL SERVE AS THE OFFICIAL LAUNCHPAD FOR ISPIRE'S NEXT-GENERATION HARDWARE SUITE.

ISPIRE TECHNOLOGY UNVEILS NEXT-GEN CANNABIS HARDWARE ECOSYSTEM AT MJBIZCON 2025

LOS ANGELES , NOV. 17, 2025 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ("ISPIRE" OR THE "COMPANY") (NASDAQ: ISPR), AN INNOVATOR IN VAPING TECHNOLOGY AND PRECISION DOSING, AND IKE TECH LLC ("IKE TECH"), A JOINT VENTURE THAT INCLUDES ISPIRE AS A FOUNDING PARTNER, RELEASED STATEMENTS FOLLOWING THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA) CONGRESSIONAL FUNDING AND DIRECTIVE TO COMBAT THE ILLICIT VAPE MARKET. AS PART OF THE CONTINUING RESOLUTION PASSED BY CONGRESS AND SIGNED BY PRESIDENT TRUMP, THE FDA IS NOW REQUIRED TO ALLOCATE AT LEAST $200 MILLION OF ITS $712 MILLION IN USER FEES TOWARD ENFORCING REGULATIONS ON ELECTRONIC NICOTINE DELIVERY SYSTEMS (ENDS).

ISPIRE TECHNOLOGY AND IKE TECH APPLAUD FDA CRACKDOWN, CALL FOR TECH-DRIVEN ENFORCEMENT TO PREVENT ILLICIT TRADE AND PROTECT YOUTH

COST CUTTING MEASURES INSTITUTED IN FISCAL 2025 HELPED CUT TOTAL OPERATING EXPENSES BY APPROXIMATELY 39% TO $7.8 MILLION YEAR-OVER-YEAR NET ACCOUNTS RECEIVABLE REDUCED APPROXIMATELY 29% FROM $62.4 MILLION TO $44.5 MILLION YEAR-OVER-YEAR CASH AND CASH EQUIVALENTS OF $22.7 MILLION AT SEPTEMBER 30, 2025  LOS ANGELES , NOV. 6, 2025 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ( NASDAQ: ISPR )("ISPIRE," THE "COMPANY," "WE," "US," OR "OUR"), AN INNOVATOR IN VAPING TECHNOLOGY AND PRECISION DOSING, TODAY REPORTED FINANCIAL RESULTS FOR THE FIRST QUARTER OF FISCAL 2026, FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025. FISCAL FIRST QUARTER 2026 FINANCIAL RESULTS REVENUE OF $30.4 MILLION VERSUS $39.3 MILLION FOR THE FIRST QUARTER OF FISCAL 2025.

ISPIRE TECHNOLOGY INC. REPORTS FINANCIAL RESULTS FOR FISCAL FIRST QUARTER 2026

LOS ANGELES , NOV. 4, 2025 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ("ISPIRE" OR THE "COMPANY") (NASDAQ: ISPR), A TRAILBLAZER IN VAPING TECHNOLOGY AND PRECISION DOSING, ANNOUNCED TODAY THAT IT WILL HOST ITS EARNINGS CONFERENCE CALL AT 8:00 AM ET ON THURSDAY, NOVEMBER 6, 2025, TO DISCUSS THE COMPANY'S FINANCIAL RESULTS FOR ITS FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2025. TO LISTEN TO THE CONFERENCE CALL, PLEASE DIAL IN USING THE INFORMATION BELOW.

Ispire Technology Inc.

ISPR

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Ispire Technology Inc.

ISPR.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

ISPR